Skip to content

Dental implants in patients with oral cancer

Implants in oral cancer patients with and without adjuvant radiotherapy. A prospective parallel arm cohort study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043348
Enrollment
30
Registered
2022-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K06- Other disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: implant placement in radiated patients: Patients who underwent radiation therapy to the head and neck region would receive implants. This would be followed by prosthetic rehabilitation.

Sponsors

Investigator Initiated Study sponsored by Oral Reconstruction Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Study design: Prospective parallel arm cohort study Inclusion criteria: Patients with hopeless prognosis teeth that require replacement. Patients with expected extended edentulous spaces during or after ablative oral cancer surgery. Can be either in upper or lower jaw. Implants to be placed in either native bone or reconstructed bone.

Exclusion criteria

Exclusion criteria: Patients with single tooth replacements or short edentulous spans of 2 teeth. Patients who have an adequately remaining functional dentition (including shortened dental arch). Patients with additional comorbidities like uncontrolled diabetes mellitus, immunotherapy, concomitant/ adjuvant/ chemotherapy.

Design outcomes

Primary

MeasureTime frame
Baseline measurements at time of implant placement: Implant stability measurements, Initial depth of implant placement (IDIP), Oral health related QoL questionnaires: OHIP, EORTC QoL, EORTC H&N. Follow up time periods: Follow up periods: 6 months and 12 months following prosthesis delivery. During each of these time periods, the following measurements will be made: 1. Clinical evaluation of peri-implant soft tissues: Plaque index (Mombelli et al, 1987); Bleeding index (Mombelli et al, 1987); Gingival index (L�¶e & Sillnes, 1963) and Probing depth. 2. Implant stability measurements by RFA 3. Radiographic evaluation of marginal bone remodellingTimepoint: Baseline measurements at time of implant placement: Implant stability measurements, Initial depth of implant placement (IDIP), Oral health related QoL questionnaires: OHIP, EORTC QoL, EORTC H&N. Follow up time periods: Follow up periods: 6 months and 12 months following prosthesis delivery. During each of these time periods, the following measurements will be made: 1. Clinical evaluation of peri-implant soft tissues: Plaque index (Mombelli et al, 1987); Bleeding index (Mombelli et al, 1987); Gingival index (L�¶e & Sillnes, 1963) and Probing depth. 2. Implant stability measurements by RFA 3. Radiographic evaluation of marginal bone remodelling

Secondary

MeasureTime frame
Oral Health Impact ProfileTimepoint: baseline, 12 months post prosthesis, 3 years post prosthesis

Countries

India

Contacts

Public ContactVinay V Kumar

Oral Rehabilitation Center

veezo@rediffmail.com9886687654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026